{"id":825809,"date":"2025-03-14T07:03:12","date_gmt":"2025-03-14T11:03:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/"},"modified":"2025-03-14T07:03:12","modified_gmt":"2025-03-14T11:03:12","slug":"skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/","title":{"rendered":"Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN DIEGO, March  14, 2025  (GLOBE NEWSWIRE) &#8212; Skye Bioscience, Inc. (Nasdaq: SKYE) (\u201cSkye\u201d), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will host a conference call on Thursday, March 20th at 1:30 p.m. PT\/4:30 p.m. ET to discuss its 2024 fourth quarter and full-year financial results. An earnings press release will be issued after the market closes on March 20th.<\/p>\n<p align=\"justify\">The live webcast of the call can be accessed at the Skye <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UpyVGQE8fhTKS5ORTE7x5Nb7kFYaZnFtbUZPT_HbwP6rMvFF--6EXWp_dbMEz9nW2QFGzuLrWgZP7So6NGfEgG43geIVlyaOI5xdpWQN5pS377dbXUEIwljYIVN1EtM6LHvz93PpEG7MV4nEq7kFdRw7sTRgtv7jveEzisQvqNM=\" rel=\"nofollow\" target=\"_blank\"><u>Investor Relations<\/u><\/a> website, along with the company&#8217;s earnings press release, financial tables, and investor presentation. Please join the call 5-10 minutes prior to the scheduled start time. Following the call, a replay and transcript will be available at the same website.<\/p>\n<p align=\"justify\">\n        <strong>About Skye Bioscience <\/strong>\n      <\/p>\n<p>Skye is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors. Skye&#8217;s strategy leverages biologic targets with substantial human proof of mechanism for the development of first-in-class therapeutics with clinical and commercial differentiation. Skye is conducting a Phase 2 clinical trial (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DrzkgpYnKE-4n5Xgam6M9fTL--tjMxH6xJy8Q6p2aPM9OE3DrVlRWzbB_b1spA9ykn_ZwIxEOuwKOZvdUjnXWrF2IkVY9IHL0OFYr2ctJbakMYApj_meeuBDsCPaweMQibRcxnaQuBh3Q7IqxI2v2A==\" rel=\"nofollow\" target=\"_blank\"><u>ClinicalTrials.gov: NCT06577090<\/u><\/a>) in obesity for nimacimab, a negative allosteric modulating antibody that peripherally inhibits CB1. This study is also assessing the combination of nimacimab and a GLP-1R agonist (Wegovy\u00ae). For more information, please visit: <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0jyfjCYpW_urxtBfLyDlgey32mU8q9Tg7za6QQSlW0waRjXaFKAnebfaG-zEa4Iuvjimo-zikh1oN3R7c_ZWol59Bw3nGKNy5zrbWnYkp14=\" rel=\"nofollow\" target=\"_blank\">www.skyebioscience.com<\/a><\/u>. Connect with us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0Eh_Q0dmHT4t32u4CKqGogPMbWQ9x4Np-EwFP3daATjImEr4iGw7DZGN4iGUU9vPmgzuM2eJp3DLOmCW4HTrxw==\" rel=\"nofollow\" target=\"_blank\"><u>X<\/u><\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2JCjUZAGhP5wxXFL0_KDq0nfNr58HJyL2IiXzvcsli4nWQ1iniVO6gVdqoVdGNdSgPUj2x7bANPEm6O58p2y35tS8y9PiwiirB_8rUiA-iZPqhDdWrFxBMfVJ77KY_K2\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>.<\/p>\n<p>\n        <strong>CONTACTS<\/strong>\n      <\/p>\n<p>Investor Relations<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RS6_LIa-1PTcyrySyZNmR2xi5ChNevCwqE0UJ1fDBAwQGBs6_dyDp3NQV8sa3DqwdY8YJ9-5pakz2r0rUtZjUXRTqmJQeiG9QFeZQsuQt6s=\" rel=\"nofollow\" target=\"_blank\">ir@skyebioscience.com<\/a><\/u><br \/>(858) 410-0266<\/p>\n<p>LifeSci Advisors, Mike Moyer<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tBHCWSdlt7LMMkwBUXDsp-NBfL7UR3AKeyfjFBYliVonk0NbwQAJV51rt2mSdga2C2WkmWUJgykovBYwhJ7oM8ASmSP0fCBm-P4nAHh_YgX9FZ6azcJvp5viQ1YPLMN-\" rel=\"nofollow\" target=\"_blank\">mmoyer@lifesciadvisors.com<\/a><\/u><br \/>(617) 308-4306<\/p>\n<p>Media Inquiries<br \/>LifeSci Communications, Michael Fitzhugh<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nhSwMVk9-nwqvocTn00LqgBrgaavbbGpezfbAqDtibZeg_eAbsc4Vtr75WnszpfNjw9HaP8dDj0OHkB8bsymHixJAV2xuaqc_2KbSF5EirH-AN9UW4JSfzmjMuuRaSXV\" rel=\"nofollow\" target=\"_blank\">mfitzhugh@lifescicomms.com<\/a><\/u><br \/>(628) 234-3889<\/p>\n<p>\n        <strong>FORWARD LOOKING STATEMENTS<\/strong><\/p>\n<p>This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, forward-looking statements can be identified by terminology including \u201canticipated,\u201d \u201cplans,\u201d \u201cgoal,\u201d \u201cfocus,\u201d \u201caims,\u201d \u201cintends,\u201d \u201cbelieves,\u201d \u201ccan,\u201d \u201ccould,\u201d \u201cchallenge,\u201d \u201cpredictable,\u201d \u201cwill,\u201d \u201cwould,\u201d \u201cmay\u201d or the negative of these terms or other comparable terminology. These forward looking statements include, but are not limited to: statements regarding our product development, statements regarding the ability of nimacimab to treat obesity or related indications, and statements regarding the therapeutic potential of nimacimab. Such statements and other statements in this press release that are not descriptions of historical facts are forward-looking statements that are based on management\u2019s current expectations and assumptions and are subject to risks and uncertainties. If such risks or uncertainties materialize or such assumptions prove incorrect, our business, operating results, financial condition, and stock price could be materially negatively affected. We operate in a rapidly changing environment, and new risks emerge from time to time. As a result, it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements the Company may make. Risks and uncertainties that may cause actual results to differ materially include, among others, our capital resources, uncertainty regarding the results of future testing and development efforts and other risks that are described in the Company\u2019s periodic filings with the Securities and Exchange Commission, including in the \u201cRisk Factors\u201d section of Skye\u2019s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q. Except as expressly required by law, Skye disclaims any intent or obligation to update these forward-looking statements.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NDQ3NyM2ODA2MTcyIzUwMDEyMDM5Nw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjUzMzI5ZjgtNTRkZS00ZTgyLThhZDQtMTdhNGFmZTUwMTc5LTUwMDEyMDM5Ny0yMDI1LTAzLTE0LWVu\/tiny\/Skye-Bioscience-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, March 14, 2025 (GLOBE NEWSWIRE) &#8212; Skye Bioscience, Inc. (Nasdaq: SKYE) (\u201cSkye\u201d), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will host a conference call on Thursday, March 20th at 1:30 p.m. PT\/4:30 p.m. ET to discuss its 2024 fourth quarter and full-year financial results. An earnings press release will be issued after the market closes on March 20th. The live webcast of the call can be accessed at the Skye Investor Relations website, along with the company&#8217;s earnings press release, financial tables, and investor presentation. Please join the call 5-10 minutes prior to the scheduled start time. Following the call, a replay and transcript will be available at &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-825809","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, March 14, 2025 (GLOBE NEWSWIRE) &#8212; Skye Bioscience, Inc. (Nasdaq: SKYE) (\u201cSkye\u201d), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will host a conference call on Thursday, March 20th at 1:30 p.m. PT\/4:30 p.m. ET to discuss its 2024 fourth quarter and full-year financial results. An earnings press release will be issued after the market closes on March 20th. The live webcast of the call can be accessed at the Skye Investor Relations website, along with the company&#8217;s earnings press release, financial tables, and investor presentation. Please join the call 5-10 minutes prior to the scheduled start time. Following the call, a replay and transcript will be available at &hellip; Continue reading &quot;Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-14T11:03:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NDQ3NyM2ODA2MTcyIzUwMDEyMDM5Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025\",\"datePublished\":\"2025-03-14T11:03:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\\\/\"},\"wordCount\":572,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5NDQ3NyM2ODA2MTcyIzUwMDEyMDM5Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\\\/\",\"name\":\"Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5NDQ3NyM2ODA2MTcyIzUwMDEyMDM5Nw==\",\"datePublished\":\"2025-03-14T11:03:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5NDQ3NyM2ODA2MTcyIzUwMDEyMDM5Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5NDQ3NyM2ODA2MTcyIzUwMDEyMDM5Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/","og_locale":"en_US","og_type":"article","og_title":"Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025 - Market Newsdesk","og_description":"SAN DIEGO, March 14, 2025 (GLOBE NEWSWIRE) &#8212; Skye Bioscience, Inc. (Nasdaq: SKYE) (\u201cSkye\u201d), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will host a conference call on Thursday, March 20th at 1:30 p.m. PT\/4:30 p.m. ET to discuss its 2024 fourth quarter and full-year financial results. An earnings press release will be issued after the market closes on March 20th. The live webcast of the call can be accessed at the Skye Investor Relations website, along with the company&#8217;s earnings press release, financial tables, and investor presentation. Please join the call 5-10 minutes prior to the scheduled start time. Following the call, a replay and transcript will be available at &hellip; Continue reading \"Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-14T11:03:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NDQ3NyM2ODA2MTcyIzUwMDEyMDM5Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025","datePublished":"2025-03-14T11:03:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/"},"wordCount":572,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NDQ3NyM2ODA2MTcyIzUwMDEyMDM5Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/","name":"Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NDQ3NyM2ODA2MTcyIzUwMDEyMDM5Nw==","datePublished":"2025-03-14T11:03:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NDQ3NyM2ODA2MTcyIzUwMDEyMDM5Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NDQ3NyM2ODA2MTcyIzUwMDEyMDM5Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2024-financial-results-on-march-20th-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/825809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=825809"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/825809\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=825809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=825809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=825809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}